Adalimumab Monoclonal Antibody from Japan
Adalimumab is a fully human monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha) and is used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease. This product is imported in bulk, unmixed form, not put up in measured doses or retail packaging, which qualifies it under tariff item 3002.13.00 as an immunological product.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the product is imported as a single, unmixed substance without stabilizers or additives, as these may shift classification
• Maintain detailed documentation proving biotechnological production and absence of retail packaging to support the tariff classification
• Verify whether a Drug Establishment Licence from Health Canada is required for the import